BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

947 related articles for article (PubMed ID: 18160603)

  • 21. Anticoagulant therapy and thromboprophylaxis in patients with thrombophilia.
    Weintraub AY; Sheiner E
    Arch Gynecol Obstet; 2007 Dec; 276(6):567-71. PubMed ID: 17828548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombophilia and its impact on pregnancy.
    Pabinger I
    Thromb Res; 2009; 123 Suppl 3():S16-21. PubMed ID: 19203641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inherited thrombophilia and pregnancy complications revisited.
    Rodger MA; Paidas M; McLintock C; Middeldorp S; Kahn S; Martinelli I; Hague W; Rosene Montella K; Greer I
    Obstet Gynecol; 2008 Aug; 112(2 Pt 1):320-4. PubMed ID: 18669729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of the long-term administration of low-molecular-weight heparins in pregnancy.
    Santoro R; Iannaccaro P; Prejanò S; Muleo G
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):240-3. PubMed ID: 19357505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of heparin in women with early and late miscarriages with and without thrombophilia.
    Monien S; Kadecki O; Baumgarten S; Salama A; Dörner T; Kiesewetter H
    Clin Appl Thromb Hemost; 2009 Dec; 15(6):636-44. PubMed ID: 19666941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial.
    Qublan H; Amarin Z; Dabbas M; Farraj AE; Beni-Merei Z; Al-Akash H; Bdoor AN; Nawasreh M; Malkawi S; Diab F; Al-Ahmad N; Balawneh M; Abu-Salim A
    Hum Fertil (Camb); 2008 Dec; 11(4):246-53. PubMed ID: 19085261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregnancy outcome in patients with a history of recurrent spontaneous miscarriages and documented thrombophilias.
    Krabbendam I; Dekker GA
    Gynecol Obstet Invest; 2004; 57(3):127-31. PubMed ID: 14691342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of anticoagulant therapy on pregnancy outcomes in patients with thrombophilia and previous poor obstetric history.
    Mutlu I; Mutlu MF; Biri A; Bulut B; Erdem M; Erdem A
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):267-73. PubMed ID: 25268607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. THE ROLE OF LOW MOLECULAR WEIGHT HEPARIN IN WOMEN WITH HEREDITARY THROMBOPHILIA FOR GOOD PERINATAL OUTCOME.
    Sokol V; Ivanišević M; Herman M; Đelmiš J
    Acta Clin Croat; 2016 Jun; 55(2):309-15. PubMed ID: 28394549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preventing adverse obstetric outcome in women with thrombophilia].
    Verspyck E
    Ann Med Interne (Paris); 2003; 154(5-6):366-9. PubMed ID: 15027592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venous thromboembolism during pregnancy.
    Dresang LT; Fontaine P; Leeman L; King VJ
    Am Fam Physician; 2008 Jun; 77(12):1709-16. PubMed ID: 18619081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical cure of severe, early onset preeclampsia with low molecular weight heparin therapy in primigravida with hyperreactio luteinalis and thrombophilia.
    Saisto T; Tiitinen A; Ulander VM; Kaaja R
    Hum Reprod; 2004 Mar; 19(3):725-8. PubMed ID: 14998977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregnancy failure and heritable thrombophilia.
    Middeldorp S
    Semin Hematol; 2007 Apr; 44(2):93-7. PubMed ID: 17433901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
    de Jong PG; Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD004734. PubMed ID: 24995856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism in at-risk pregnant women: a review.
    Duhl AJ
    J Reprod Med; 2008 Sep; 53(9):657-66. PubMed ID: 18839817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Birth outcomes in pregnant women treated with low-molecular-weight heparin.
    Sørensen HT; Johnsen SP; Larsen H; Pedersen L; Nielsen GL; Møller M
    Acta Obstet Gynecol Scand; 2000 Aug; 79(8):655-9. PubMed ID: 10949230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia.
    Kupferminc M; Rimon E; Many A; Maslovitz S; Lessing JB; Gamzu R
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):123-6. PubMed ID: 21192252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of aspirin versus aspirin and heparin in cases of recurrent abortions with raised anticardiolipin antibodies.
    Goel N; Tuli A; Choudhry R
    Med Sci Monit; 2006 Mar; 12(3):CR132-6. PubMed ID: 16501426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment with enoxaparin adapted to the fertility programs in women with recurrent abortion and thrombophilia].
    Sarto A; Rocha M; Geller M; Capmany C; Martínez M; Quintans C; Donaldson M; Pasqualini RS
    Medicina (B Aires); 2001; 61(4):406-12. PubMed ID: 11563168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent miscarriage and thrombophilia: an update.
    McNamee K; Dawood F; Farquharson R
    Curr Opin Obstet Gynecol; 2012 Aug; 24(4):229-34. PubMed ID: 22729089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.